Acceso abierto

Association between Inflammatory Markers and Clinical and Metabolic Risk Factors for Cardiovascular Diseases

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.'s Cover Image
Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
The National Research Programme On Main Diseases Threatening The Life Expectancy and Life Quality of The Latvian Population: Scientific papers

Cite

Alber, H.F., Wanitschek, M.M., de Waha, S., Ladurner, A., Suessenbacher, A., Dorler, J., Dichtl, W., Frick, M., Ulmer, H., Pachinger, O., Weidinger, F. (2008). High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur. J. Clin. Invest., 38(6), 372-380.10.1111/j.1365-2362.2008.01954.xSearch in Google Scholar

Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new world wide definition. Lancet, 366, 1059-1062.10.1016/S0140-6736(05)67402-8Search in Google Scholar

Berg, A.H., Scherer, P.E. (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ. Res., 96, 939-949.10.1161/01.RES.0000163635.62927.3415890981Search in Google Scholar

Bilgili, S.C.A., Dogan, A., Karaca, B. (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr. Regul., 42(1), 63-68.Search in Google Scholar

Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23(1), 57-63.10.2337/diacare.23.1.5710857969Search in Google Scholar

Caglayan, E.C., Blaschke, F., Takata, Y., Hsueh, W.A. (2005). Metabolic syndrome — interdependence of the cardiovascular and metabolic pathways. Curr. Opin. Pharmacol., 5, 135-142.10.1016/j.coph.2005.01.00815780821Search in Google Scholar

Calabro, P., Limongelli, G., Pacileo, G., Di Salvo, G., Golino, P. (2008). The role of adiposity as a determinant of an inflammatory milieu. J. Cardiovasc. Med., 9(5), 450-460.10.2459/JCM.0b013e3282eee9a818403996Search in Google Scholar

Calabro, P., Yeh, E.T.H. (2008). Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk. Curr. Hypertens. Rep., 10, 32-38.10.1007/s11906-008-0008-z18367024Search in Google Scholar

El-Menyar, A.A. (2008). Cytokines and coronary artery disease: The state of the art. Crit. Pathw. Cardiol., 7(2), 139-151.10.1097/HPC.0b013e31816713d918520532Search in Google Scholar

Espinola-Klein, Ch., Rupprecht, H.J., Bickel, Ch., Lackner, K., Genth-Zotz, S., Post, F., Munzel, T., Blankenberg, S. (2008). Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome. Eur. J. Cardiovasc. Prev. Rehab., 15, 278-284.10.1097/HJR.0b013e3282f37a6e18525381Search in Google Scholar

Florentin, M., Liberopoulus, E.N., Wierzbicki, A.S., Mikhailidis, D.P. (2008). Multiple actions of high-density lipoprotein. Curr. Opin. Cardiol., 23, 370-378.10.1097/HCO.0b013e328304380618520722Search in Google Scholar

Fuster, V., Sanz, J. (2008). Atherothrombosis: Past, present and future. Revista Argentina de Cardiologia, 76, spec. ed., 51-54.Search in Google Scholar

Gimeno, R.E., Klaman, L.D. (2005). Adipose tissue as an active endocrine organ: Recent advances. Curr. Opin. Pharmacol., 5, 122-128.10.1016/j.coph.2005.01.006Search in Google Scholar

Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G.D., Kremastinos, D.Th. (2008). Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis, 199, 3-11.10.1016/j.atherosclerosis.2008.02.019Search in Google Scholar

Kahn, R., Buse, J., Ferrannini, E., Stern, M. (2005). The metabolic syndrome: Time for a critical cppraisal. Diabetes Care, 28(9), 2289-2304.10.2337/diacare.28.9.2289Search in Google Scholar

Khera, A., Mc Guire, D.K., Murphy, A.S., Stanek, H.S., Das, S.R., Vongpatanasin, W., Wians, F.H., Jr, Grundy, S.M., Lemos, J.A. (2005). Race and gender differences in C-reactive protein levels. J. Amer. Coll. Cardiol, 46(3), 464-469.10.1016/j.jacc.2005.04.051Search in Google Scholar

Lago, F., Diequez, C., Gomez-Reino, J., Gualillo, O. (2007). Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Practice Rheumatol., 3(12), 716-725.10.1038/ncprheum0674Search in Google Scholar

Matsuzawa, Y. (2006). The metabolic syndrome and adipocytokines. FEBS Letters, 580, 2917-2921.10.1016/j.febslet.2006.04.028Search in Google Scholar

Miles, E.A., Rees, D., Banerjee, T., Cazzola, R., Lewis, S., Wood, R., Oates, R., Tallant, A., Cestaro, B., Yaqoob, P., Wahle, K.W., Calder, P.C. (2008). Age related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis, 196, 298-305.10.1016/j.atherosclerosis.2006.11.002Search in Google Scholar

Nilson, J. (2005). CRP-marker or marker of cardiovascular disease? Arterioscler. Thromb. Vasc. Biol., 25, 1527-1528.10.1161/01.ATV.0000174796.81443.3fSearch in Google Scholar

Pi-Sunyer, F.X. (2006). The relation of adipose tissue to cardiometabolic risk. Clin. Cornerstone, 8 (Suppl. 4), S14-S23.10.1016/S1098-3597(06)80040-2Search in Google Scholar

Rosenson, R.S. (2005). New approaches in the intensive management of cardiovascular risk in the metabolic syndrome. Curr. Probl. Cardiol., 30(5), 241-280.10.1016/j.cpcardiol.2004.10.00115829899Search in Google Scholar

Ross, R. (1999). Atherosclerosis — An inflammatory disease. New Engl. J. Med., 340, 115-126.10.1056/NEJM1999011434002079887164Search in Google Scholar

Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, F., Laakso, M. (2008). Gender difference in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in metabolic syndrome: A population-based study. Diabetes Med., 25(6), 747-750.10.1111/j.1464-5491.2008.02440.x18435780Search in Google Scholar

Taeye, B.D., Smith, L.H., Vaughan, D.E. (2005). Plasminogen activator inhibitor-1 a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol., 5, 149-154.10.1016/j.coph.2005.01.00715780823Search in Google Scholar

Virani, S.S., Polsani, V.R., Nambi, V. (2008). Novel markers of inflammation in atherosclerosis. Curr. Atheroscl. Rep., 10(2), 164-170.10.1007/s11883-008-0024-018417072Search in Google Scholar

ISSN:
1407-009X
Idioma:
Inglés
Calendario de la edición:
6 veces al año
Temas de la revista:
General Interest, Mathematics, General Mathematics